Stryker
Stryker Corporation is a global leader in medical technology that develops, manufactures, and markets a diverse array of innovative healthcare solutions. The company's core value proposition centers on improving patient and hospital outcomes through advanced surgical equipment, neurotechnology, and orthopaedic implants. Its mission is driven by a commitment to innovation, quality, and service across approximately 75 countries.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
MedSurg and Neurotechnology
primaryThis segment provides surgical equipment, navigation systems, and neurovascular devices used in minimally invasive and traditional brain surgeries. It also includes patient handling, emergency medical equipment, and AI-assisted virtual care platforms.
SurgiCount+ powered by Triton, CoPilot, 1788 Camera platform, LIFEPAK 35 monitor/defibrillator, Surpass Elite Flow Diverting Stent, Surpass Evolve FDS, Vocera
Hospitals, Emergency medical services, Neurosurgeons, Intensive care units
Orthopaedics
majorThis segment focuses on implants used in total joint replacements, such as hips, knees, and shoulders, as well as trauma and extremities surgeries. It leverages robotic-arm assisted technology to enhance surgical precision and recovery.
Mako SmartRobotics, Triathlon Hinge revision knee system, Novae monolithic dual mobility cup, Pangea plating portfolio, Perform Reversed Glenoid implant, Mako Total Hip
Orthopaedic surgeons, Outpatient surgery centers, Hospitals, Trauma centers
Segment Financials
MedSurg and Neurotechnology: — Capital Expenditures During Period
View metricMedSurg and Neurotechnology: — Reallocation of goodwill from MedSurg and Neurotechnology segments
View metricOrthopaedics — Reallocation of goodwill from MedSurg and Neurotechnology segments
View metricOrthopaedics — Capital Expenditures During Period
View metricBusiness Overview
Competitive Position
Stryker is a leading global competitor across all its primary product lines, maintaining a significant market share in orthopaedic robotics and surgical instrumentation.
Geographies
United States, Canada, Japan, South Korea, Europe, New Zealand
Customer Segments
Hospitals, Specialized Surgeons, Healthcare Facilities, Emergency Responders
Upstream Dependencies
Raw material suppliers, Single-source component manufacturers, Specialized sterilization service providers
Downstream Customers
Hospitals, Healthcare facilities, Third-party dealers, Medical distributors
Competitors & Partners
Competitors
Medtronic
MDT
Competitor in Instruments and Neurotechnology
Boston Scientific
BSX
Global medical device competitor
Johnson & Johnson
JNJ
Competitor in Instruments, Neurotechnology, and Orthopaedics
Intuitive Surgical
ISRG
Major competitor in medical instruments and orthopedic robotics.
Zimmer Biomet Holdings
ZBH
Competitor in Instruments and Orthopaedics
Penumbra
PEN
Competitor in Neurotechnology
Baxter International
BAX
Competitor in Medical segment
CONMED
CNMD
Competitor in Instruments and Endoscopy
STERIS
STE
Healthcare segment competitor
Partners
Arthrex, Inc.
Competitor in the Endoscopy market space
Subsidiaries
Vertos Medical, Inc.
Acquired leader in interventional pain management solutions
care.ai
Acquired virtual care and ambient intelligence platform
SERF SAS
Acquired European orthopaedics manufacturer
Vocera Communications
Clinical communication platform integrated into Medical business
Stryker FAQ
Common questions about Stryker
Stryker Corporation is a global leader in medical technology that develops, manufactures, and markets a diverse array of innovative healthcare solutions. The company's core value proposition centers on improving patient and hospital outcomes through advanced surgical equipment, neurotechnology, and orthopaedic implants. Its mission is driven by a commitment to innovation, quality, and service across approximately 75 countries.
Stryker (SYK) has a market capitalization of $121.33B and trades on NYSE.
Stryker generated $25.3B in trailing twelve-month revenue with net income of $3.3B, representing a net margin of 13.2%. Gross margin stands at 63.8%, with free cash flow of $4.6B. These figures are based on the Q1 2026 filing.
Stryker's key competitors include Medtronic plc, Boston Scientific Corporation, Johnson & Johnson MedTech, and others. These companies compete in similar markets and product categories.
Stryker has approximately 52,000 employees.